Active ingredient(s): Methylnaltrexone Bromide

Dosage form: subcutaneous injection

Manufacturer: Progenics

Usage: Treatment of opioid-induced constipation (OIC) in patients with advanced illness who are receiving palliative care, when response to laxative therapy has not been sufficient.

Approval Date: April 24, 2008

For more information visit http://www.wyeth.com/hcp/relistor/landing

Disclaimer: All contents published on RxInfoBlog.com is provided for informational and educational purposes only. Like any printed material, it may become out-of-date over time.  The site and its services are not a substitute for professional medical advice and treatment. Always seek the advice of your doctor before making any changes to your diet, health routine, or treatment.

Active ingredient(s): Certolizumab Pegol 200mg

Dosage form: 200mg lyophilized powder for reconstitution with 1ml of sterile water for injection

Manufacturer: UCB

Usage: reducing signs and symptoms of Crohn’s disease and maintaining clinical reponse in adult patients with moderately to severely active disease who have had an inadequate response to conventional therapy.

Approval Date: April 22, 2008

For more information visit http://www.cimzia.com/Default1.asp?v=GOOG

Disclaimer: All contents published on RxInfoBlog.com is provided for informational and educational purposes only. Like any printed material, it may become out-of-date over time.  The site and its services are not a substitute for professional medical advice and treatment. Always seek the advice of your doctor before making any changes to your diet, health routine, or treatment.

Active ingredient(s): olopatadine

Dosage form: nasal spray

Manufacturer: Alcon

Usage: Relief of the symptoms of seasonal allergic rhinitis in patients 12 years of age and older.

Approval Date: April 15, 2008

For more information visit http://www.patanase.com/

Disclaimer: All contents published on RxInfoBlog.com is provided for informational and educational purposes only. Like any printed material, it may become out-of-date over time.  The site and its services are not a substitute for professional medical advice and treatment. Always seek the advice of your doctor before making any changes to your diet, health routine or treatment.

Active ingredient(s): sumatriptan 85mg and naproxen sodium 500mg

Dosage form: tablets

Manufacturer: GlaxoSmithKline

Usage: Acute treatment of migraine attacks with or without aura in adults.  It is not intended for the prophylactic therapy of migraine or use in the management of hemiplegic or basilar migraine.  Safety and effectiveness have not been established for cluster headache.

Approval Date: April 15, 2008

For more information visit http://www.treximet.com/

Disclaimer: All contents published on RxInfoBlog.com is provided for informational and educational purposes only. Like any printed material, it may become out-of-date over time.  The site and its services are not a substitute for professional medical advice and treatment. Always seek the advice of your doctor before making any changes to your diet, health routine or treatment.